-
1
-
-
33846025408
-
A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition
-
Akdede B.B., Anil Yaǧcioǧlu A.E., Alptekin K., Turgut T.I., Tümüklü M., Yazici M.K., Jayathilake K., Tunca Z., Göǧü A., Meltzer H.Y. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition. Journal of Clinical Psychiatry 2006, 67:1912-1919.
-
(2006)
Journal of Clinical Psychiatry
, vol.67
, pp. 1912-1919
-
-
Akdede, B.B.1
Anil Yaǧcioǧlu, A.E.2
Alptekin, K.3
Turgut, T.I.4
Tümüklü, M.5
Yazici, M.K.6
Jayathilake, K.7
Tunca, Z.8
Göǧü, A.9
Meltzer, H.Y.10
-
2
-
-
18144442184
-
Effect of the treatment of type II diabetes mellitus on the development of cognitive impairment and dementia
-
Areosa S.A., Grimley E.J. Effect of the treatment of type II diabetes mellitus on the development of cognitive impairment and dementia. Cochrane Database of Systematic Reviews 4 2002, CD003408.
-
(2002)
Cochrane Database of Systematic Reviews 4
-
-
Areosa, S.A.1
Grimley, E.J.2
-
3
-
-
9644291424
-
The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function
-
Awad N., Gagnon M., Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. Journal of Clinical and Experimental Neuropsychology 2004, 26:1044-1080.
-
(2004)
Journal of Clinical and Experimental Neuropsychology
, vol.26
, pp. 1044-1080
-
-
Awad, N.1
Gagnon, M.2
Messier, C.3
-
5
-
-
0032572613
-
Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment
-
Biessels G.J., Kamal A., Urban I.J., Spruijt B.M., Erkelens D.W., Gispen W.H. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment. Brain Research 1998, 27:125-135.
-
(1998)
Brain Research
, vol.27
, pp. 125-135
-
-
Biessels, G.J.1
Kamal, A.2
Urban, I.J.3
Spruijt, B.M.4
Erkelens, D.W.5
Gispen, W.H.6
-
6
-
-
1842684436
-
Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface
-
Biessels G.J., Bravenboer B., Gispen W.H. Glucose, insulin and the brain: modulation of cognition and synaptic plasticity in health and disease: a preface. European Journal of Pharmacology 2004, 490:1-4.
-
(2004)
European Journal of Pharmacology
, vol.490
, pp. 1-4
-
-
Biessels, G.J.1
Bravenboer, B.2
Gispen, W.H.3
-
7
-
-
0027083366
-
Antipsychotic medication effects on neuropsychological functions
-
Bilder R.M., Turkel E., Lipschutz-Broch L., Lieberman J.A. Antipsychotic medication effects on neuropsychological functions. Psychopharmacology Bulletin 1992, 28:353-366.
-
(1992)
Psychopharmacology Bulletin
, vol.28
, pp. 353-366
-
-
Bilder, R.M.1
Turkel, E.2
Lipschutz-Broch, L.3
Lieberman, J.A.4
-
8
-
-
0034651101
-
Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists
-
Combs C.K., Johnson D.E., Karlo J.C., Cannady S.B., Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. Journal of Neuroscience 2000, 20:558-567.
-
(2000)
Journal of Neuroscience
, vol.20
, pp. 558-567
-
-
Combs, C.K.1
Johnson, D.E.2
Karlo, J.C.3
Cannady, S.B.4
Landreth, G.E.5
-
9
-
-
1242316296
-
Insulin and neurodegenerative disease: shared and specific mechanisms
-
Craft S., Watson G.S. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurology 2004, 3:169-178.
-
(2004)
Lancet Neurology
, vol.3
, pp. 169-178
-
-
Craft, S.1
Watson, G.S.2
-
10
-
-
65349113335
-
Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem
-
Dickinson D., Harvey P.D. Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem. Schizophrenia Bulletin 2009, 35:403-414.
-
(2009)
Schizophrenia Bulletin
, vol.35
, pp. 403-414
-
-
Dickinson, D.1
Harvey, P.D.2
-
11
-
-
58149485983
-
Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model
-
Escribano L., Simón A.M., Pérez-Mediavilla A., Salazar-Colocho P., Del Río J., Frechilla D. Rosiglitazone reverses memory decline and hippocampal glucocorticoid receptor down-regulation in an Alzheimer's disease mouse model. Biochemical and Biophysical Research Communications 2009, 379:406-410.
-
(2009)
Biochemical and Biophysical Research Communications
, vol.379
, pp. 406-410
-
-
Escribano, L.1
Simón, A.M.2
Pérez-Mediavilla, A.3
Salazar-Colocho, P.4
Del Río, J.5
Frechilla, D.6
-
12
-
-
0029918481
-
What are the functional consequences of neurocognitive deficits in schizophrenia?
-
Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia?. American Journal of Psychiatry 1996, 153:321-330.
-
(1996)
American Journal of Psychiatry
, vol.153
, pp. 321-330
-
-
Green, M.F.1
-
13
-
-
0003968285
-
-
Psychological Assessment Resources, Odessa, FL
-
Heaton R.K. Wisconsin Card Sort Manual 1981, Psychological Assessment Resources, Odessa, FL.
-
(1981)
Wisconsin Card Sort Manual
-
-
Heaton, R.K.1
-
14
-
-
0034042934
-
Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five year naturalistic study
-
Henderson D.C., Cagliero E., Gray C., Nasrallah R.A., Hayden D.L., Schoenfeld D.A., Goff D.C.. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five year naturalistic study. American Journal of Psychiatry 2000, 157:975-981.
-
(2000)
American Journal of Psychiatry
, vol.157
, pp. 975-981
-
-
Henderson, D.C.1
Cagliero, E.2
Gray, C.3
Nasrallah, R.A.4
Hayden, D.L.5
Schoenfeld, D.A.6
Goff, D.C..7
-
15
-
-
19944429395
-
Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis
-
Henderson D.C., Cagliero E., Copeland P.M., Borba C.P., Evins E., Hayden D., Weber M.T., Anderson E.J., Allison D.B., Daley T.B., Schoenfeld D., Goff D.C. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis. Archives of General Psychiatry 2005, 62:19-28.
-
(2005)
Archives of General Psychiatry
, vol.62
, pp. 19-28
-
-
Henderson, D.C.1
Cagliero, E.2
Copeland, P.M.3
Borba, C.P.4
Evins, E.5
Hayden, D.6
Weber, M.T.7
Anderson, E.J.8
Allison, D.B.9
Daley, T.B.10
Schoenfeld, D.11
Goff, D.C.12
-
16
-
-
34247470659
-
Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics
-
Henderson D.C., Cagliero E., Copeland P.M., Louie P.M., Borba C.P., Fan X., Freudenreich O., Goff D.C. Elevated hemoglobin A1c as a possible indicator of diabetes mellitus and diabetic ketoacidosis in schizophrenia patients receiving atypical antipsychotics. Journal of Clinical Psychiatry 2007, 68:533-541.
-
(2007)
Journal of Clinical Psychiatry
, vol.68
, pp. 533-541
-
-
Henderson, D.C.1
Cagliero, E.2
Copeland, P.M.3
Louie, P.M.4
Borba, C.P.5
Fan, X.6
Freudenreich, O.7
Goff, D.C.8
-
17
-
-
65749100954
-
A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia
-
Henderson D.C., Fan X., Sharma B., Copeland P.M., Borba C.P., Boxill R., Freudenreich O., Cather C., Eden Evins A., Goff D.C. A double-blind, placebo-controlled trial of rosiglitazone for clozapine-induced glucose metabolism impairment in patients with schizophrenia. Acta Psychiatrica Scandinavica 2009, 119:457-465.
-
(2009)
Acta Psychiatrica Scandinavica
, vol.119
, pp. 457-465
-
-
Henderson, D.C.1
Fan, X.2
Sharma, B.3
Copeland, P.M.4
Borba, C.P.5
Boxill, R.6
Freudenreich, O.7
Cather, C.8
Eden Evins, A.9
Goff, D.C.10
-
18
-
-
0028142146
-
Severe hyperglycemia associated with high doses of clozapine
-
Kamran A., Doraiswamy P.M., Jane J.L., Hammett E.B., Dunn L. Severe hyperglycemia associated with high doses of clozapine. American Journal of Psychiatry 1994, 151:1395.
-
(1994)
American Journal of Psychiatry
, vol.151
, pp. 1395
-
-
Kamran, A.1
Doraiswamy, P.M.2
Jane, J.L.3
Hammett, E.B.4
Dunn, L.5
-
19
-
-
77049120142
-
Investigation of clinical factors influencing cognitive function in Japanese schizophrenia
-
Kishi T., Moriwaki M., Kawashima K., Okochi T., Fukuo Y., Kitajima T., Furukawa O., Naitoh H., Fujita K., Iwata N. Investigation of clinical factors influencing cognitive function in Japanese schizophrenia. Neuroscience Research 2010, 66:340-344.
-
(2010)
Neuroscience Research
, vol.66
, pp. 340-344
-
-
Kishi, T.1
Moriwaki, M.2
Kawashima, K.3
Okochi, T.4
Fukuo, Y.5
Kitajima, T.6
Furukawa, O.7
Naitoh, H.8
Fujita, K.9
Iwata, N.10
-
20
-
-
0035893949
-
Clozapine-associated diabetes
-
Koller E., Schneider B., Bennett K., Dubitsky G. Clozapine-associated diabetes. American Journal of Medicine 2001, 111:716-723.
-
(2001)
American Journal of Medicine
, vol.111
, pp. 716-723
-
-
Koller, E.1
Schneider, B.2
Bennett, K.3
Dubitsky, G.4
-
21
-
-
77952545095
-
Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance
-
McNay E.C., Ong C.T., McCrimmon R.J., Cresswell J., Bogan J.S., Sherwin R.S. Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance. Neurobiology of Learning and Memory 2010, 93:546-553.
-
(2010)
Neurobiology of Learning and Memory
, vol.93
, pp. 546-553
-
-
McNay, E.C.1
Ong, C.T.2
McCrimmon, R.J.3
Cresswell, J.4
Bogan, J.S.5
Sherwin, R.S.6
-
22
-
-
0032977410
-
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia
-
Meltzer H.Y., McGurk S.R. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophrenia Bulletin 1999, 25:233-255.
-
(1999)
Schizophrenia Bulletin
, vol.25
, pp. 233-255
-
-
Meltzer, H.Y.1
McGurk, S.R.2
-
23
-
-
70450247208
-
Management of schizophrenia with obesity, metabolic, and endocrinological disorders
-
Monteleone P., Martiadis V., Maj M. Management of schizophrenia with obesity, metabolic, and endocrinological disorders. Psychiatric Clinics of North America 2009, 32:775-794.
-
(2009)
Psychiatric Clinics of North America
, vol.32
, pp. 775-794
-
-
Monteleone, P.1
Martiadis, V.2
Maj, M.3
-
24
-
-
0030972350
-
Cognitive function in schizophrenia-do neuroleptics make a difference?
-
Mortimer A. Cognitive function in schizophrenia-do neuroleptics make a difference?. Pharmacology, Biochemistry, and Behavior 1997, 56:789-795.
-
(1997)
Pharmacology, Biochemistry, and Behavior
, vol.56
, pp. 789-795
-
-
Mortimer, A.1
-
26
-
-
0242609178
-
Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase
-
Sastre M., Dewachter I., Landreth G.E., Willson T.M., Klockgether T., van Leuven F., Heneka MT. Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. Journal of Neuroscience 2003, 23:9796-9804.
-
(2003)
Journal of Neuroscience
, vol.23
, pp. 9796-9804
-
-
Sastre, M.1
Dewachter, I.2
Landreth, G.E.3
Willson, T.M.4
Klockgether, T.5
van Leuven, F.6
Heneka, M.T.7
-
27
-
-
0033389121
-
Construct and concurrent validity of the Hopkins Verbal Learning Test-Revised
-
Shapiro A.M., Benedict R.H., Schretlen D., Brandt J. Construct and concurrent validity of the Hopkins Verbal Learning Test-Revised. Clinical Neuropsychologist 1999, 13:348-358.
-
(1999)
Clinical Neuropsychologist
, vol.13
, pp. 348-358
-
-
Shapiro, A.M.1
Benedict, R.H.2
Schretlen, D.3
Brandt, J.4
-
28
-
-
0026769858
-
The Structured Clinical Interview for DSM-III-R (SCID). I. History, rationale, and description
-
Spitzer R.L., Williams J.B., Gibbon M., First M.B. The Structured Clinical Interview for DSM-III-R (SCID). I. History, rationale, and description. Archives of General Psychiatry 1992, 49:624-629.
-
(1992)
Archives of General Psychiatry
, vol.49
, pp. 624-629
-
-
Spitzer, R.L.1
Williams, J.B.2
Gibbon, M.3
First, M.B.4
-
29
-
-
0037221379
-
The role of insulin-resistance in the pathogenesis of Alzheimer's disease: implication for treatment
-
Watson G.S., Craft S. The role of insulin-resistance in the pathogenesis of Alzheimer's disease: implication for treatment. CNS Drugs 2003, 17:27-45.
-
(2003)
CNS Drugs
, vol.17
, pp. 27-45
-
-
Watson, G.S.1
Craft, S.2
-
30
-
-
33644592598
-
Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study
-
Watson G.S., Cholerton B.A., Reger M.A., Baker L.D., Plymate S.R., Asthana S., Fishel M.A., Kulstad J.J., Green P.S., Cook D.G., Kahn S.E., Keeling M.L., Craft S. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. American Journal of Geriatric Psychiatry 2005, 13:950-958.
-
(2005)
American Journal of Geriatric Psychiatry
, vol.13
, pp. 950-958
-
-
Watson, G.S.1
Cholerton, B.A.2
Reger, M.A.3
Baker, L.D.4
Plymate, S.R.5
Asthana, S.6
Fishel, M.A.7
Kulstad, J.J.8
Green, P.S.9
Cook, D.G.10
Kahn, S.E.11
Keeling, M.L.12
Craft, S.13
-
32
-
-
77449145659
-
Cognitive impairment of executive function as a core symptom of schizophrenia
-
Wobrock T., Ecker U.K., Scherk H., Schneider-Axmann T., Falkai P., Gruber O. Cognitive impairment of executive function as a core symptom of schizophrenia. World Journal of Biological Psychiatry 2009, 10:442-451.
-
(2009)
World Journal of Biological Psychiatry
, vol.10
, pp. 442-451
-
-
Wobrock, T.1
Ecker, U.K.2
Scherk, H.3
Schneider-Axmann, T.4
Falkai, P.5
Gruber, O.6
|